Clarifying the Epidemiologic Implications of the 2025 Hypertension Canada Guideline
Canadian Journal of Cardiology · 2026-11 · 42 (11) · 2760
DOI: 10.1016/j.cjca.2026.06.016 ↗Kurz gefasst
Leserbrief in der Zeitschrift Canadian Journal of Cardiology, 2026-11. Verfasst von Rémi Goupil. Beteiligte Einrichtung: Department of Medicine, Université de Montréal, Montreal, Canada. Electronic address: remi.goupil@umontreal.ca. Die Arbeit nennt 2 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Université de Montréal, Montreal, Canada. Electronic address: remi.goupil@umontreal.ca.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Goupil, R. (2026). Clarifying the Epidemiologic Implications of the 2025 Hypertension Canada Guideline. Canadian Journal of Cardiology, 42(11), 2760. https://doi.org/10.1016/j.cjca.2026.06.016
Vancouver
Goupil R. Clarifying the Epidemiologic Implications of the 2025 Hypertension Canada Guideline. Canadian Journal of Cardiology. 2026;42(11):2760. doi:10.1016/j.cjca.2026.06.016
BibTeX
@article{Goupil2026,
author = {Goupil, Rémi},
title = {Clarifying the Epidemiologic Implications of the 2025 Hypertension Canada Guideline},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {11},
pages = {2760},
doi = {10.1016/j.cjca.2026.06.016}
}
EUVIMED